Griffith DE, Thomson R, Addrizzo-Harris DJ, et al. Sustainability and durability of culture conversion in patients receiving amikacin liposome inhalation suspension (ALIS) for treatment-refractory mycobacterium avium complex lung disease (MAC-LD) in the CONVERT Study. Am J Resp Crit Care Med. 2019;199:A7358.
COVID-19-vaccinatie veilig, immunogeen en effectief bij kinderen van 5-11 jaar
jan 2022 | Vaccinatie, Virale infecties